1. Home
  2. PRTA vs ASTE Comparison

PRTA vs ASTE Comparison

Compare PRTA & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • ASTE
  • Stock Information
  • Founded
  • PRTA 2012
  • ASTE 1972
  • Country
  • PRTA Ireland
  • ASTE United States
  • Employees
  • PRTA N/A
  • ASTE N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • ASTE Construction/Ag Equipment/Trucks
  • Sector
  • PRTA Health Care
  • ASTE Industrials
  • Exchange
  • PRTA Nasdaq
  • ASTE Nasdaq
  • Market Cap
  • PRTA 809.8M
  • ASTE 706.4M
  • IPO Year
  • PRTA N/A
  • ASTE N/A
  • Fundamental
  • Price
  • PRTA $15.27
  • ASTE $35.99
  • Analyst Decision
  • PRTA Buy
  • ASTE Hold
  • Analyst Count
  • PRTA 9
  • ASTE 2
  • Target Price
  • PRTA $54.57
  • ASTE $39.00
  • AVG Volume (30 Days)
  • PRTA 396.4K
  • ASTE 189.0K
  • Earning Date
  • PRTA 05-07-2025
  • ASTE 04-30-2025
  • Dividend Yield
  • PRTA N/A
  • ASTE 1.45%
  • EPS Growth
  • PRTA N/A
  • ASTE N/A
  • EPS
  • PRTA N/A
  • ASTE 0.19
  • Revenue
  • PRTA $135,157,000.00
  • ASTE $1,305,100,000.00
  • Revenue This Year
  • PRTA N/A
  • ASTE $7.12
  • Revenue Next Year
  • PRTA $106.71
  • ASTE $4.29
  • P/E Ratio
  • PRTA N/A
  • ASTE $190.66
  • Revenue Growth
  • PRTA 47.92
  • ASTE N/A
  • 52 Week Low
  • PRTA $11.70
  • ASTE $28.46
  • 52 Week High
  • PRTA $30.86
  • ASTE $44.74
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 54.26
  • ASTE 53.13
  • Support Level
  • PRTA $13.89
  • ASTE $33.21
  • Resistance Level
  • PRTA $16.16
  • ASTE $35.61
  • Average True Range (ATR)
  • PRTA 1.14
  • ASTE 1.33
  • MACD
  • PRTA 0.04
  • ASTE 0.28
  • Stochastic Oscillator
  • PRTA 53.11
  • ASTE 63.78

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

Share on Social Networks: